{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:07:23Z","timestamp":1791580043049,"version":"4.3.4"},"reference-count":24,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Vitamin K may play an important role in the prevention of fractures in postmenopausal women with osteoporosis. Menatetrenone is the brand name of a synthetic vitamin K2 that is chemically identical to menaquinone-4. The present review study aimed to clarify the effect of menatetrenone on the skeleton in postmenopausal women with osteoporosis, by reviewing the results of randomized controlled trials (RCTs) in the literature. RCTs that investigated the effect of menatetrenone on bone mineral density (BMD), measured by dual-energy X-ray absorptiometry and fracture incidence in postmenopausal women with osteoporosis, were identified by a PubMed search for literature published in English. Eight studies met the criteria for RCTs. Small RCTs showed that menatetrenone monotherapy decreased serum undercarboxylated osteocalcin (ucOC) concentrations, modestly increased lumbar spine BMD, and reduced the incidence of fractures (mainly vertebral fracture), and that combined alendronate and menatetrenone therapy enhanced the decrease in serum ucOC concentrations and further increased femoral neck BMD. This review of the literature revealed positive evidence for the effects of menatetrenone monotherapy on fracture incidence in postmenopausal women with osteoporosis. Further studies are required to clarify the efficacy of menatetrenone  in combination with bisphosphonates against fractures in postmenopausal women  with osteoporosis.<\/jats:p>","DOI":"10.3390\/nu6051971","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T12:09:04Z","timestamp":1400242144000},"page":"1971-1980","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Vitamin K2 Therapy for Postmenopausal Osteoporosis"],"prefix":"10.3390","volume":"6","author":[{"given":"Jun","family":"Iwamoto","sequence":"first","affiliation":[{"name":"Institute for Integrated Sports Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2014,5,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","article-title":"Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone","volume":"69","author":"Hauschka","year":"1989","journal-title":"Physiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1359\/jbmr.1997.12.3.431","article-title":"Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro","volume":"12","author":"Koshihara","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(95)90227-9","article-title":"Vitamin K","volume":"345","author":"Shearer","year":"1995","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nu.15.070195.000245","article-title":"Role of vitamin K in bone metabolism","volume":"15","author":"Vermeer","year":"1995","journal-title":"Annu. Rev. Nutr."},{"key":"ref_5","first-page":"254","article-title":"Usefulness of serum undercarboxylated osteocalcin measurement as a predictor for clinical fractures","volume":"18","author":"Tsugawa","year":"2010","journal-title":"Osteoporos. Jpn."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00774-010-0167-2","article-title":"High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment","volume":"28","author":"Shiraki","year":"2010","journal-title":"J. Bone Miner. Metab."},{"key":"ref_7","first-page":"1249","article-title":"Clinical evaluation of soft capsule menatetrenone (Ea-0167) in the treatment of osteoporosis. Late Phase II Dose Study","volume":"41","author":"Orimo","year":"1992","journal-title":"J. New Rem. Clin."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11657-012-0109-9","article-title":"Japanese 2011 guidelines for prevention and treatment of osteoporosis-executive summary","volume":"7","author":"Orimo","year":"2012","journal-title":"Arch. Osteoporos."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.nutres.2009.03.012","article-title":"High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: A review of the literature","volume":"29","author":"Iwamoto","year":"2009","journal-title":"Nutr. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1359\/jbmr.2000.15.3.515","article-title":"Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis","volume":"15","author":"Shiraki","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s007760100002","article-title":"Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: A comparison with the effect of etidronate","volume":"6","author":"Iwamoto","year":"2001","journal-title":"J. Orthop. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.amjmed.2004.05.019","article-title":"Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study","volume":"117","author":"Ishida","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00774-008-0008-8","article-title":"Randomized controlled study on the prevention of osteoporotic fractures (OF Study): A phase IV clinical study of 15-mg menatetrenone capsules","volume":"27","author":"Inoue","year":"2009","journal-title":"J. Bone Miner. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s007760070003","article-title":"Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis","volume":"5","author":"Iwamoto","year":"2000","journal-title":"J. Orthop. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-5122(01)00275-4","article-title":"Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women","volume":"41","author":"Ushiroyama","year":"2002","journal-title":"Maturitas"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1447-0756.2006.00386.x","article-title":"Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia","volume":"32","author":"Purwosunu","year":"2006","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_17","first-page":"121","article-title":"Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: A multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial","volume":"9","author":"Jiang","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00774-008-0034-6","article-title":"Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: A randomized prospective study","volume":"27","author":"Shiraki","year":"2009","journal-title":"J. Bone Miner. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00774-007-0823-3","article-title":"Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women","volume":"26","author":"Hirao","year":"2008","journal-title":"J. Bone Miner. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/382448a0","article-title":"Increased bone formation in osteocalcin-deficient mice","volume":"382","author":"Ducy","year":"1996","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00198-007-0337-9","article-title":"Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women","volume":"18","author":"Knapen","year":"2007","journal-title":"Osteoporos. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature09464","article-title":"Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme","volume":"468","author":"Nakagawa","year":"2010","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1371\/journal.pmed.0050196","article-title":"Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): A randomized controlled trial","volume":"5","author":"Cheung","year":"2008","journal-title":"PLoS Med."},{"key":"ref_24","unstructured":"(1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser., 843, 1\u2013129."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/6\/5\/1971\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:11:32Z","timestamp":1760217092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/6\/5\/1971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,16]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5]]}},"alternative-id":["nu6051971"],"URL":"https:\/\/doi.org\/10.3390\/nu6051971","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,16]]}}}